Equity · Healthcare
OPK
NASDAQOPKO Health (OPK)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.
- Market cap
- 1.1B USD
- Revenue, year to Dec 2025
- 606.9M USD
- EPS, diluted, year to Dec 2025
- −0.30 USD
- 52-week range
- 1 USD – 1.62 USD
- Avg volume
- 714.7K
as of Aug 26, 2026
Have OPKO Health (OPK) insiders bought or sold shares recently?
In the 90 days to 22 Nov 2026, OPKO Health insiders reported 1 open-market sale and no purchases (SEC Form 4); none has bought on the open market since 20 Mar 2026.
Form 4, 90 days to 22 Nov 2026, newest reported trade 5 Nov 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 05 Nov 2026 | PAGANELLI JOHN ADirector | Sell | 13,601 | 25K USD |
Which funds hold OPKO Health (OPK)?
8 of the 45 institutional funds we track reported a OPKO Health position for the quarter ended 30 Sep 2026 — a combined 9.0M USD; the latest of those filings landed 16 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Citadel Advisors | Added | 2,771,536 | 4.5M USD | +95.1% |
| Renaissance Technologies | New position | 1,011,218 | 1.6M USD | |
| Two Sigma Investments | Added | 694,859 | 1.1M USD | +295.3% |
| AQR Capital Management | Trimmed | 301,744 | 486K USD | −75.7% |
| Tudor Investment Corp | Held (±25%) | 244,821 | 394K USD | |
| Point72 Asset Management | Added | 242,987 | 391K USD | +67.3% |
| GAMCO Investors | Held (±25%) | 175,000 | 282K USD | |
| Millennium Management | Added | 137,297 | 221K USD | +89.9% |
What has been filed or recorded for OPKO Health (OPK)?
The filings we hold for OPKO Health, newest first: 7 fails-to-deliver days, 3 quarterly earnings reports, 4 annual reports and 5 reported financial figures, the latest dated 27 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 27 Oct 2026 | Fails to deliver | Shares failed to deliver | 453 shares | 738 USD notional · <0.001% of shares out |
| 26 Oct 2026 | Fails to deliver | Shares failed to deliver | 32,119 shares | 52K USD notional · 0.004% of shares out |
| 19 Oct 2026 | Fails to deliver | Shares failed to deliver | 197,323 shares | 302K USD notional · 0.027% of shares out |
| 16 Oct 2026 | Fails to deliver | Shares failed to deliver | 219,574 shares | 354K USD notional · 0.030% of shares out |
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 374 shares | 516 USD notional · <0.001% of shares out |
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 21,536 shares | 30K USD notional · 0.003% of shares out |
| 07 Oct 2026 | Fails to deliver | Shares failed to deliver | 19,534 shares | 29K USD notional · 0.003% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.07 USD | Revenue $65M |
| 30 Sep 2026 | Financials | Total assets | 1.9B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 1.1B USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.01 USD | Revenue $164M |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.07 USD | Revenue $124M |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −0.04 USD | Revenue $148M |
| 31 Dec 2025 | Financials | Revenue | 606.9M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −225.7M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −0.30 USD | fiscal year |
| 30 Sep 2025 | Annual report | FY 2025 reported | EPS 0.03 USD | Revenue $152M |
| 30 Jun 2025 | Annual report | FY 2025 reported | EPS −0.19 USD | Revenue $157M |
| 31 Mar 2025 | Annual report | FY 2025 reported | EPS −0.10 USD | Revenue $150M |
What do people ask about OPKO Health (OPK)?
What did OPKO Health shares close at?1.51
OPKO Health closed at 1.51 USD on 26 Aug 2026, up 1.68% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is OPKO Health’s market cap?1.1B
OPKO Health is worth 1.1B USD by market value as of 26 Aug 2026, which is the share price times the shares on issue from its SEC filings.
What is OPKO Health’s revenue?606.9M
OPKO Health reported revenue of 606.9M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have OPKO Health insiders bought or sold shares recently?1 sale
In the 90 days to 22 Nov 2026, OPKO Health insiders reported 1 open-market sale and no purchases (SEC Form 4); none has bought on the open market since 20 Mar 2026. See Insiders
Which funds own OPKO Health?8 of 45
8 of the 45 funds we track reported a OPKO Health position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Citadel Advisors, Renaissance Technologies and Two Sigma Investments. See Funds
When did OPKO Health last report earnings?−0.07
OPKO Health last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.07 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings
- SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words